Morpholino

MO1-aqp1a.1

ID
ZDB-MRPHLNO-131023-4
Name
MO1-aqp1a.1
Previous Names
None
Target
Sequence
5' - AAGCCTTGCTCTTCAGCTCGTTCAT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-aqp1a.1
Phenotype
Phenotype resulting from MO1-aqp1a.1
Phenotype of all Fish created by or utilizing MO1-aqp1a.1
Phenotype Fish Conditions Figures
integument proton export across plasma membrane decreased process quality, abnormal AB + MO1-aqp1a.1 control Fig. 4 from Horng et al., 2015
ionocyte proton export across plasma membrane decreased process quality, abnormal AB + MO1-aqp1a.1 control Fig. 5 from Horng et al., 2015
vH ionocyte proton export across plasma membrane decreased process quality, abnormal AB + MO1-aqp1a.1 control Fig. 5 from Horng et al., 2015
vH ionocyte proton export across plasma membrane process quality, ameliorated AB + MO1-aqp1a.1 hypercapnia Fig. 5 from Horng et al., 2015
respiratory gaseous exchange by respiratory system process quality, abnormal WT + MO1-aqp1a.1 chemical treatment by environment: phenylhydrazine Fig. 6 from Talbot et al., 2015
pectoral artery aqp1a.1 expression decreased amount, abnormal WT + MO1-aqp1a.1 standard conditions Fig. 1 from Talbot et al., 2015
carbon dioxide transport decreased process quality, abnormal WT + MO1-aqp1a.1 control Fig. 2Fig. 6 from Talbot et al., 2015
gill aqp1a.1 expression decreased amount, abnormal WT + MO1-aqp1a.1 standard conditions Fig. 1 from Talbot et al., 2015
ammonium transmembrane transport decreased process quality, abnormal WT + MO1-aqp1a.1 chemical treatment by environment: phenylhydrazine Fig. 6 from Talbot et al., 2015
water transport decreased process quality, abnormal WT + MO1-aqp1a.1 standard conditions Fig. 1 from Talbot et al., 2015
ammonium transmembrane transport decreased process quality, abnormal WT + MO1-aqp1a.1 control Fig. 3Fig. 6 from Talbot et al., 2015
whole organism aqp1a.1 expression decreased amount, abnormal WT + MO1-aqp1a.1 standard conditions Fig. 1 from Talbot et al., 2015
heart aqp1a.1 expression decreased amount, abnormal WT + MO1-aqp1a.1 standard conditions Fig. 1 from Talbot et al., 2015
oxygen transport decreased process quality, abnormal WT + MO1-aqp1a.1 chemical treatment by environment: phenylhydrazine Fig. 6 from Talbot et al., 2015
oxygen transport decreased process quality, abnormal WT + MO1-aqp1a.1 control Fig. 6 from Talbot et al., 2015
carbon dioxide transport decreased process quality, abnormal WT + MO1-aqp1a.1 chemical treatment by environment: phenylhydrazine Fig. 6 from Talbot et al., 2015
respiratory gaseous exchange by respiratory system process quality, abnormal WT + MO1-aqp1a.1 control Fig. 2Fig. 6 from Talbot et al., 2015
Citations